Hepatocellular carcinoma (HCC) is the most common malignancy worldwide, and is
especially common in China. A total of 70%–80% of patients are diagnosed at an advanced …

For most cancers, the treatment of choice is still chemotherapy despite its severe adverse
effects, systemic toxicity and limited efficacy due to the development of multidrug resistance …

Hepatocellular carcinoma (HCC) is a leading cause of cancer related deaths worldwide. It
was suggested that albendazole (ABZ) is a powerful inhibitor of several carcinoma types …

The overexpression of the MDM2 oncoprotein frequently occurs in hepatocellular carcinoma
(HCC). Small molecules that inhibit MDM2-p53 binding show efficacy against p53 wild-type …

Hepatocellular carcinoma (HCC) is an inflammation-related malignant tumor that develops
from underlying cirrhosis. As HCC is a common tumor seen in clinical practice, its prevention …

Carnosic acid (CA), an important bioactive phenolic diterpene mainly found in labiate plants,
exerts various biological functions, including antioxidant, anti-inflammatory, antitumor, and …

Overexpression of the MDM2 oncogene and mutations in the p53 tumor suppressor
commonly occur in hepatocellular carcinoma (HCC) and are associated with increased …

Hepatocellular carcinoma (HCC) is characterized by bad prognosis and is the second most
common reason for cancer-linked mortality. Treatment with sorafenib (SRF) alone increases …

Introduction Early and non-invasive detection of hepatocellular carcinoma (HCC), which is
usually asymptomatic, can improve overall survival outcomes. The objective of this …

Liver cancer primarily accounts for the majority of malignancies of the liver. MicroRNAs
(miRNAs) are endogenous non‑coding RNAs, which are important in tumorigenesis …